Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196954
Max Phase: Preclinical
Molecular Formula: C26H34N4O
Molecular Weight: 418.59
Associated Items:
ID: ALA5196954
Max Phase: Preclinical
Molecular Formula: C26H34N4O
Molecular Weight: 418.59
Associated Items:
Canonical SMILES: CN1C=C2C[C@@H]3[C@H](C[C@@H](CNC(=O)[C@@H](N)Cc4ccccc4)CN3C)C3C=CC=C1C23
Standard InChI: InChI=1S/C26H34N4O/c1-29-15-18(14-28-26(31)22(27)12-17-7-4-3-5-8-17)11-21-20-9-6-10-23-25(20)19(13-24(21)29)16-30(23)2/h3-10,16,18,20-22,24-25H,11-15,27H2,1-2H3,(H,28,31)/t18-,20?,21+,22-,24+,25?/m0/s1
Standard InChI Key: ZNHMOLJKAJXDOF-OOLUEVKGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 418.59 | Molecular Weight (Monoisotopic): 418.2733 | AlogP: 2.53 | #Rotatable Bonds: 5 |
Polar Surface Area: 61.60 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.09 | CX LogP: 1.35 | CX LogD: -2.57 |
Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.77 | Np Likeness Score: 0.85 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):